SCHEMBL1394914

SCHEMBL1394914

CCCCCCCCC=CCCCCCCCC(=O)C(O)C(O)(C(=O)CCCCCCCCCCCCCCCCC)C(O)C(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.58
▸ CES1 P23141 2/20 0.58
▸ TERT O14746 3/20 0.51
▸ PTPN1 P18031 3/20 0.51
▸ PPARG P37231 3/20 0.51
▸ PPARD Q03181 3/20 0.51
▸ PPARA Q07869 3/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ BLM P54132 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ FABP4 P15090 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ GMNN O75496 1/20 0.51
▸ USP2 O75604 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20337835 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL20448270 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL9718666 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL639669 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL21632566 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL22558683 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL637887 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL21641563 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL22282517 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG
SCHEMBL2575053 1.00 FAAH (0.58) FAAHCES1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120009321-A1 METHOD FOR PRODUCING FATS AND OILS THE NISSHIN OILLIO GROUP, LTD. (JP) 2012-01-12 — — US disclosed
EP-2404985-A1 PROCESS FOR PRODUCING OIL-AND-FAT The Nisshin OilliO Group, Ltd. (JP) 2012-01-11 — — EP disclosed
US-7906147-B2 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography NANOPROBES, INC. (US) 2011-03-15 — — US disclosed
US-20100028523-A1 Fat-and-oil compositions for inhibiting the migration of water in food and foods made by using the same ASAMA KOJI 2010-02-04 — — US disclosed
US-20090022875-A1 Fat-and-oil compositions for inhibiting the migration of water in food and foods made by using the same FUJI OIL COMPANY, LIMITED (JP) 2009-01-22 — — US disclosed
US-20080089836-A1 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography NANOPROBES, INC. (US) 2008-04-17 — — US disclosed
EP-1787521-A1 FAT-AND-OIL COMPOSITIONS FOR INHIBITING THE MIGRATION OF WATER IN FOOD AND FOODS MADE BY USING THE SAME Fuji Oil Company, Ltd. (JP) 2007-05-23 — — EP disclosed
WO-1992012421-A1 A METHOD OF ANALYSIS OF FATTY ACIDS IN TRIACYLGLYCEROLS KALLIO HEIKKI PAAVO TAPIO (FI) 1992-07-23 — — WO disclosed
WO-1991007168-A1 RIBOFLAVIN AS A TANNING ENHANCER SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) 1991-05-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080089836-A1 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography TFRC, FABP1, SCARB1 FAAH 205/4885CES1 1877/4885TERT 4688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback